期刊文献+

126例中年肺癌患者临床特点及预后分析 被引量:4

Clinical characteristics and prognosis of 126 cases in middle-aged patients with lung cancer
下载PDF
导出
摘要 目的探索中年肺癌患者临床特点并进行预后分析。方法回顾性分析2009年1月至2011年12月术后病理证实的126例中年肺癌患者的临床病理资料,采用Kaplan-Meier法和Cox回归进行中年肺癌患者预后的单因素及多因素生分析。结果 126例中年肺癌患者5年无病生存率(FDS)和总体生存率(OS)分别为40.4%和45.2%。单因素分析发现患者的肿瘤复发与淋巴转移(P=0.002)、病理类型(P=0.031)和TNM分期(P<0.001)有关;而多因素分析提示TNM分期为影响中年肺癌患者肿瘤复发的独立危险因子,并随着TNM分期的增高相对危险度增加(HR:I期0.148 vs.II期0.227 vs.IIIA期0.421 vs.IIIB/IV期1)。同时单因素分析发现淋巴转移(P=0.007)、胸膜转移(P=0.001)和TNM分期(P<0.001)与患者生存有关;多因素分析提示胸膜转移(P=0.007)和TNM分期(P<0.001)为影响中年肺癌患者生存的独立危险因子。结论 TNM分期和胸膜侵犯与中年肺癌患者预后相关,并且TNM分期是影响中年肺癌患者预后的独立危险因子。 Objective To explore the clinical features and prognostic factors of middle-aged patients with lung cancer. Methods The clinicopathological data of 126 middle-aged patients with lung cancer was retrospectively analyzed by using univariate ( Log-rank) and multivariate ( Cox model) methods.Results 5-year disease-free survival ( FDS) and over-all survival (OS) in 126 cases of middle-aged patients with lung cancer was 40.4%and 45.2%respectively.Malignancy recurrence was related with lymph node metastasis (P=0.002), histological type (P=0.031) and TNM stage (P〈0.001) using Kaplan Meier survival analysis.However, only TNM stage was an independent risk factor affecting relapse, and the higher TNM grade the more increased relative risk.Simultaneously overall survival was associated with lymph node metastasis (P=0.007), pleural metastasis (P=0.001) and TNM stage (P〈0.001).Moreover, pleural metastasis and TNM stage were independent risk factors affecting survival of middle-aged patients with lung cancer.Conclusion TNM staging and pleural invasion are associated with prognosis of the middle-aged patients with lung cancer.TNM staging is an independent risk factor affecting the prognosis of middle-aged patients with lung cancer.
出处 《大连医科大学学报》 CAS 2015年第5期451-454,共4页 Journal of Dalian Medical University
基金 国家自然科学基金项目(81173453) 大连市科技计划重大项目(2012E15SF141)
关键词 中年 肺癌 预后 middle age lung cancer prognosis
  • 相关文献

参考文献7

二级参考文献55

  • 1赵永刚,庞丽.8例细支气管肺泡癌误诊为粟粒型肺结核的临床分析[J].临床肺科杂志,2006,11(3):349-349. 被引量:2
  • 2赵弘卿,张熔熔,王利军,殷伯福,殷凯生.痰液hnRNP A2/B1在肺癌临床诊断中的价值[J].江苏医药,2006,32(12):1121-1122. 被引量:1
  • 3覃红娟,劳献宁,刘秋玲,陈华.肺结核并存肺癌59例临床分析[J].临床肺科杂志,2007,12(3):233-234. 被引量:13
  • 4Goldstraw P, Crowley JJ; On behalf of the IASLC International Staging Project. The international association for the study of lung cancer international staging project on lung cancer. J Thorac Oncol 2006; 1:281-286.
  • 5Rami-Porta R, Ball D, Crowley JJ, et al. International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM cJassification for lung cancer. J Thorac Oncol 2007;2:593- 602.
  • 6Kusch VW, Crowley JJ, Giroux DJ, et al. International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM dassification for lung cancer. J Thorac Oncol 2007;2:603- 612.
  • 7Postmus PE, Brambilla E, Chansky K, et al. International Association for the Study of Lung Cancer International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC lung cancer staging project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007;2:686-693.
  • 8Goldstraw P, Crowley JJ, Chansky K, et al. International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;8:706 - 714.
  • 9Sculier Jp, Chansky K, CrowleyJJ, et al. International Staging Committee and Participating Institutions. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition. J Thorac Oncol 2008;3:4,57- 466.
  • 10Groome PA, Bolejack V, Crowley JJ, et al. IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC lung cancer staging project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:694 -705.

共引文献50

同被引文献42

  • 1郭兵,崔静萍.保密与否对肺癌患者影响的临床观察[J].中国临床保健杂志,2007,10(5):520-521. 被引量:5
  • 2DE RUYSSEHER D,PARIS E,LE PECHOUX C,et al. A meta-a- nalysis of randomized trials using individual patient data on the tim- ing of chest radiotherapy in patients with limited stage small cell lung cancer[J]. J Thorac Oneol,2011,6(Suppl 2) :S641-S642.
  • 3O' BRIEN M E,KONOPA K,LORIGAN P,et al. Randomised phase Ⅱ study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer-EORTC 08062[J]. Eur J Cancer, 2011, 47 (15)= 2322-2330.
  • 4REKHTMAN N. Neuroendocrine tumors of the lung: an update[J]. Arch Pathol Lab Med,2010,134(ll)=1628-1637.
  • 5ROSSI A, MATELLI O, DI MAIO M. Treatment of patients with small cell lung cancer: from meta-analyses to clinical practice[J]. Cancer Treat Rev,2013,39(5):498-506.
  • 6KAMINSKYY V O, SUROVA O V, VACULOVA A, et al. Com- bined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL [J]. Carcinogenesis,2011,32(10): 1450-1458.
  • 7VARLOTTO J M, RECHT A, FLICKINGER J C, et al. Lobectomy leads to optimal survival in early-stage small cell lung cancen a retrospective a- nalysis[J]. Thorac Cardiovasc Surg, 2011,142 (3) : 538-546.
  • 8VAN MEERBEECK J P,FENNELL D A,DE RUYSSCHER D K. Small-cell lung cancer[J]. Lancet, 2011,378(9804) : 1741- 1755.
  • 9SUDU T, DOMAGA KULAWIK J. Clinical manifestation and ra- diological features of small cell lung cancer (SCLC)[J]. Wiad Lek, 2012,65(2) :97.
  • 10布桂林.60例小细胞肺癌的CT表现[J].华西医学,2009,24(4):945-946. 被引量:3

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部